Investor Relations
Welcome to MedVasc's Investor Relations website!
We appreciate your interest in our company and we are dedicated to providing all our current and future investors with timely and transparent information. If you have any questions, regarding our traction, investment strategy or future opportunities for investment, please feel free to reach out to CEO Cathrin Johansson.
Stay up to date on our performance and future investment opportunities by signing up to our newsletter.
Latest news
MedVasc secures SEK 24 Million financing and advances Solutio™ toward FDA clearance
January 29, 2026
MedVasc AB has successfully completed production and testing activities in accordance with its previously communicated plan. In parallel, the company closed a new financing…
MedVasc Selected to Present at Prestigious MedTech Pitch Day by HGTF 2025
May 7, 2025
One of Only 10 Startups Chosen from 86 Applicants to Pitch Before Leading Central European MedTech Investors Lund, Sweden, May 6, 2025 – MedVasc…
MedVasc raises SEK 10 Million to accelerate final development and FDA preparation for Solutio™ device
May 7, 2025
Lund, Sweden – May 6, 2025 – MedVasc AB, a Swedish medical technology company announces the successful closing of a SEK 10 million financing round…
MedVasc secures SEK 24 Million financing and advances Solutio™ toward FDA clearance
January 29, 2026
MedVasc AB has successfully completed production and testing activities in accordance with its previously communicated plan. In parallel, the company closed a new financing…
MedVasc Selected to Present at Prestigious MedTech Pitch Day by HGTF 2025
May 7, 2025
One of Only 10 Startups Chosen from 86 Applicants to Pitch Before Leading Central European MedTech Investors Lund, Sweden, May 6, 2025 – MedVasc…
MedVasc raises SEK 10 Million to accelerate final development and FDA preparation for Solutio™ device
May 7, 2025
Lund, Sweden – May 6, 2025 – MedVasc AB, a Swedish medical technology company announces the successful closing of a SEK 10 million financing round…
